Charles River Labs International (Phase II-IV Clinical Service Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Charles River Labs International (Phase II-IV Clinical Service Business) General Information

Description

Provider of clinical services intended for drug development. The company provides clinical trial services for the phase two, three, and four development stages of drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 251 Ballardvale Street
  • Wilmington, MA 01887
  • United States
Primary Industry
Drug Discovery
Acquirer
Kendle International
Corporate Office
  • 251 Ballardvale Street
  • Wilmington, MA 01887
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Charles River Labs International (Phase II-IV Clinical Service Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Charles River Labs International (Phase II-IV Clinical Service Business)‘s full profile, request access.

Request a free trial

Charles River Labs International (Phase II-IV Clinical Service Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Charles River Labs International (Phase II-IV Clinical Service Business)‘s full profile, request access.

Request a free trial

Charles River Labs International (Phase II-IV Clinical Service Business) FAQs

  • Where is Charles River Labs International (Phase II-IV Clinical Service Business) headquartered?

    Charles River Labs International (Phase II-IV Clinical Service Business) is headquartered in Wilmington, MA.

  • What industry is Charles River Labs International (Phase II-IV Clinical Service Business) in?

    Charles River Labs International (Phase II-IV Clinical Service Business)’s primary industry is Drug Discovery.

  • Is Charles River Labs International (Phase II-IV Clinical Service Business) a private or public company?

    Charles River Labs International (Phase II-IV Clinical Service Business) is a Private company.

  • What is the current valuation of Charles River Labs International (Phase II-IV Clinical Service Business)?

    The current valuation of Charles River Labs International (Phase II-IV Clinical Service Business) is .

  • What is Charles River Labs International (Phase II-IV Clinical Service Business)’s current revenue?

    The current revenue for Charles River Labs International (Phase II-IV Clinical Service Business) is .

  • Who are Charles River Labs International (Phase II-IV Clinical Service Business)’s investors?

    Charles River Laboratories International has invested in Charles River Labs International (Phase II-IV Clinical Service Business).

  • When was Charles River Labs International (Phase II-IV Clinical Service Business) acquired?

    Charles River Labs International (Phase II-IV Clinical Service Business) was acquired on 16-Aug-2006.

  • Who acquired Charles River Labs International (Phase II-IV Clinical Service Business)?

    Charles River Labs International (Phase II-IV Clinical Service Business) was acquired by Kendle International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process